CP-301

N/A

Report date: 2024/10/18 09:42:54
NME

Base Information

Drug NameCP-301
Drug Alias NameCP-301
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionRNA interference
TargetsNot applicable
Therapy Area/IndicationsPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesContera Pharma A/SVernalis Research Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVernalis Research LtdContera Pharma A/S
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A